ProfileGDS4718 / 200846_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 97% 89% 97% 96% 97% 96% 97% 97% 97% 97% 97% 97% 97% 96% 96% 97% 97% 96% 86% 98% 97% 97% 97% 96% 98% 97% 95% 96% 94% 96% 95% 96% 98% 97% 96% 96% 96% 97% 89% 97% 96% 96% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.105697
GSM549102patient 115, normal, homogenized [OPG study]10.845597
GSM549104patient 119, normal, homogenized [OPG study]9.0547289
GSM549108patient 138, normal, homogenized [OPG study]10.775697
GSM549119patient 077, normal, homogenized [OPG study]10.522496
GSM549133patient 032, cancer, homogenized [OPG study]10.957197
GSM549139patient 042, cancer, homogenized [OPG study]10.445396
GSM549099patient 107, normal, homogenized [OPG study]10.909497
GSM549109patient 139, normal, homogenized [OPG study]10.993397
GSM549110patient 046, normal, homogenized [OPG study]11.106497
GSM549114patient 063, normal, homogenized [OPG study]11.115197
GSM549122patient 082, normal, homogenized [OPG study]10.884497
GSM549134patient 033, cancer, homogenized [OPG study]10.884597
GSM549136patient 036, cancer, homogenized [OPG study]10.745397
GSM549140patient 044, cancer, homogenized [OPG study]10.62996
GSM549111patient 047, normal, homogenized [OPG study]10.630996
GSM549113patient 057, normal, homogenized [OPG study]11.124497
GSM549132patient 031, cancer, homogenized [OPG study]10.85797
GSM549137patient 038, cancer, homogenized [OPG study]10.452696
GSM549142patient 047, cancer, homogenized [OPG study]8.2622886
GSM549100patient 110, normal, homogenized [OPG study]11.261298
GSM549107patient 135, normal, homogenized [OPG study]11.154897
GSM549115patient 068, normal, homogenized [OPG study]11.31597
GSM549116patient 072, normal, homogenized [OPG study]11.105697
GSM549120patient 078, normal, homogenized [OPG study]10.614396
GSM549131patient 030, cancer, homogenized [OPG study]11.177498
GSM549118patient 074, normal, homogenized [OPG study]11.007497
GSM549129patient 027, cancer, homogenized [OPG study]10.020995
GSM549123patient 088, normal, homogenized [OPG study]10.68596
GSM549124patient 006, cancer, homogenized [OPG study]9.7833894
GSM549126patient 015, cancer, homogenized [OPG study]10.498196
GSM549128patient 025, cancer, homogenized [OPG study]10.151795
GSM549103patient 117, normal, homogenized [OPG study]10.629796
GSM549117patient 073, normal, homogenized [OPG study]11.50798
GSM549138patient 041, cancer, homogenized [OPG study]11.04497
GSM549141patient 045, cancer, homogenized [OPG study]10.61696
GSM549130patient 028, cancer, homogenized [OPG study]10.399396
GSM549101patient 111, normal, homogenized [OPG study]10.613396
GSM549105patient 128, normal, homogenized [OPG study]10.847397
GSM549106patient 134, normal, homogenized [OPG study]9.2375889
GSM549112patient 048, normal, homogenized [OPG study]11.149497
GSM549125patient 011, cancer, homogenized [OPG study]10.454696
GSM549127patient 024, cancer, homogenized [OPG study]10.336396
GSM549135patient 035, cancer, homogenized [OPG study]10.836297